Ultrasonication of Sugary -2 Corn for Enhanced Enzymatic Hydrolysis

This study investigates the potential application of high powered ultrasonics as a liquefaction pretreatment of sugary-2 corn slurry. Ground sugary-2 corn ( Zea Mays L. ) slurry was treated with ultrasonics at 20kHz and amplitudes of 192-320 µ m pp (peak-to-peak) for 5, 10, 15, 20 and 40 seconds. After sonication, enzymes (Stargen TM 001) were added to the samples to hydrolyze the starch into fermentable sugars. It was found that the reducing sugar released in the treated samples were 6-fold higher than in the non-treated samples. Scanning electron microscopy images revealed that the sugary starch was partially gelatinized during sonication. This observation was confirmed by polarized-light microscopic images, where deformed “Maltese crosses” were found. The swelling rate of sonicated samples was nearly 66 times higher than when applying conventional heating. This result confirms better gelatinization capability of ultrasonics compared to conventional heating. The maximum relative net energy gain (additional chemically released energy) of the sonicated samples was at 5s of sonication time with a power setting between 248-330W. The findings in this study indicated ultrasonics as a promising pretreatment step in sugary-2 corn hydrolysis

Ultrasonic Pretreatment of Corn Slurry in Batch and Continuous Systems

The effects of ultrasonication of corn slurry, on particle size distribution and enzymatic hydrolysis was studied for the dry-grind mill ethanol industry. Two independent ultrasonic experiments were conducted at a frequency of 20 kHz; in batch and continuous systems. The ground corn slurry (33% m/v) was pumped at flow rates 10-28 L/min in continuous flow experiments, and sonicated at constant amplitude (20µmpeak-to-peak(p-p)). Ultrasonic batch experiments were conducted at varying amplitudes of 192-320µmp-p. After ultrasonication, StargenTM001 enzyme was added to the samples and a short 3h hydrolysis followed. The treated samples were found to yield 2-3 times more reducing sugar compared to the control (untreated) samples. In terms of energy density, the batch ultrasonic system was found to deliver 25-times more energy than the continuous flow systems. Although the experiments conducted in continuous system released less reducing sugar than the batch system, the continuous system was more energy efficient. The particle size of the sonicated corn slurry (both batch and continuous) was reduced relative to the controls (without treatment). The reduction of particle size was directly proportional to the energy input during sonication. The study suggests that both batch and continuous flow ultrasonic systems enhances enzymatic hydrolysis yield, reduces particle size of corn slurry and could be a potential effective pretreatment for corn slurry

Ultrasonication in Soy Processing for Enhanced Protein and Sugar Yields and Subsequent Bacterial Nisin Production

Soy protein recovery from hexane-defatted soybean flakes using conventional methods is generally low. Importantly, some tightly-bound sugar in the soy flakes ends up in soy protein, thereby deteriorating the usefulness and quality of soy protein as a food ingredient. This research investigated the use of high-power ultrasound prior to soy protein extraction to simultaneously enhance protein yield and facilitate more sugar release in soy whey. The nutrient-rich soy whey was then used as a cheap growth medium to produce high-value nisin using Lactococcus lactis subsp. lactis. A nisin sensitive organism Micrococcus luteus was used as an indicator organism for international unit determination of nisin production as compared to standard. Soy flakes and water was mixed at the ratio of 1:10 (w/w). The slurry was then sonicated for 15, 30, 60 and 120 sec at a frequency of 20 kHz. The ultrasonic amplitude was maintained at 84 µmpp (peak to peak amplitude in µm) for all sonication durations. The results showed that with ultrasound pretreatment, the protein yield improved as much as by 46% in soy extract and sugar release by 50% with respect to nonsonicated samples (control). To maximize nisin production from soy whey, different parameters, such as aeration/agitation and incubation period were optimized. Nisin production from standard medium, DeMan, Rogosa and Sharpe (MRS) and soy whey was tested and compared. Maximum nisin production was achieved in stationary conditions and showed a continuous increase in yield till 48h of incubation (incubation period beyond that was not tested). Maximum nisin yield of 1.78 g/L of soy whey was obtained at 30°C and pH of 4.5 as opposed to 2.96 g/L of nisin with MRS medium

Nanobubbles in water and wastewater treatment systems:Small bubbles making big difference

Since the discovery of nanobubbles (NBs) in 1994, NBs have been attracting growing attention for their fascinating properties and have been studied for application in various environmental fields, including water and wastewater treatment. However, despite the intensive research efforts on NBs' fundamental properties, especially in the past five years, controversies and disagreements in the published literature have hindered their practical implementation. So far, reviews of NB research have mainly focused on NBs' role in specific treatment processes or general applications, highlighting proof-of-concept and success stories primarily at the laboratory scale. As such, there lacks a rigorous review that authenticates NBs' potential beyond the bench scale. This review aims to provide a comprehensive and up-to-date analysis of the recent progress in NB research in the field of water and wastewater treatment at different scales, along with identifying and discussing the challenges and prospects of the technology. Herein, we systematically analyze (1) the fundamental properties of NBs and their relevancy to water treatment processes, (2) recent advances in NB applications for various treatment processes beyond the lab scale, including over 20 pilot and full-scale case studies, (3) a preliminary economic consideration of NB-integrated treatment processes (the case of NB-flotation), and (4) existing controversies in NBs research and the outlook for future research. This review is organized with the aim to provide readers with a step-by-step understanding of the subject matter while highlighting key insights as well as knowledge gaps requiring research to advance the use of NBs in the wastewater treatment industry

Increased Hydrogen Production by Genetic Engineering of Escherichia coli

Escherichia coli is capable of producing hydrogen under anaerobic growth conditions. Formate is converted to hydrogen in the fermenting cell by the formate hydrogenlyase enzyme system. The specific hydrogen yield from glucose was improved by the modification of transcriptional regulators and metabolic enzymes involved in the dissimilation of pyruvate and formate. The engineered E. coli strains ZF1 (ΔfocA; disrupted in a formate transporter gene) and ZF3 (ΔnarL; disrupted in a global transcriptional regulator gene) produced 14.9, and 14.4 µmols of hydrogen/mg of dry cell weight, respectively, compared to 9.8 µmols of hydrogen/mg of dry cell weight generated by wild-type E. coli strain W3110. The molar yield of hydrogen for strain ZF3 was 0.96 mols of hydrogen/mol of glucose, compared to 0.54 mols of hydrogen/mol of glucose for the wild-type E. coli strain. The expression of the global transcriptional regulator protein FNR at levels above natural abundance had a synergistic effect on increasing the hydrogen yield in the ΔfocA genetic background. The modification of global transcriptional regulators to modulate the expression of multiple operons required for the biosynthesis of formate hydrogenlyase represents a practical approach to improve hydrogen production

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: A systematic analysis from the Global Burden of Disease Study 2016

Background: A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthcare Access and Quality (HAQ) Index for 195 countries and territories, as well as subnational locations in seven countries, from 1990 to 2016. Methods Drawing from established methods and updated estimates from GBD 2016, we used 32 causes from which death should not occur in the presence of effective care to approximate personal health-care access and quality by location and over time. To better isolate potential effects of personal health-care access and quality from underlying risk factor patterns, we risk-standardised cause-specific deaths due to non-cancers by location-year, replacing the local joint exposure of environmental and behavioural risks with the global level of exposure. Supported by the expansion of cancer registry data in GBD 2016, we used mortality-to-incidence ratios for cancers instead of risk-standardised death rates to provide a stronger signal of the effects of personal health care and access on cancer survival. We transformed each cause to a scale of 0-100, with 0 as the first percentile (worst) observed between 1990 and 2016, and 100 as the 99th percentile (best); we set these thresholds at the country level, and then applied them to subnational locations. We applied a principal components analysis to construct the HAQ Index using all scaled cause values, providing an overall score of 0-100 of personal health-care access and quality by location over time. We then compared HAQ Index levels and trends by quintiles on the Socio-demographic Index (SDI), a summary measure of overall development. As derived from the broader GBD study and other data sources, we examined relationships between national HAQ Index scores and potential correlates of performance, such as total health spending per capita. Findings In 2016, HAQ Index performance spanned from a high of 97\ub71 (95% UI 95\ub78-98\ub71) in Iceland, followed by 96\ub76 (94\ub79-97\ub79) in Norway and 96\ub71 (94\ub75-97\ub73) in the Netherlands, to values as low as 18\ub76 (13\ub71-24\ub74) in the Central African Republic, 19\ub70 (14\ub73-23\ub77) in Somalia, and 23\ub74 (20\ub72-26\ub78) in Guinea-Bissau. The pace of progress achieved between 1990 and 2016 varied, with markedly faster improvements occurring between 2000 and 2016 for many countries in sub-Saharan Africa and southeast Asia, whereas several countries in Latin America and elsewhere saw progress stagnate after experiencing considerable advances in the HAQ Index between 1990 and 2000. Striking subnational disparities emerged in personal health-care access and quality, with China and India having particularly large gaps between locations with the highest and lowest scores in 2016. In China, performance ranged from 91\ub75 (89\ub71-93\ub76) in Beijing to 48\ub70 (43\ub74-53\ub72) in Tibet (a 43\ub75-point difference), while India saw a 30\ub78-point disparity, from 64\ub78 (59\ub76-68\ub78) in Goa to 34\ub70 (30\ub73-38\ub71) in Assam. Japan recorded the smallest range in subnational HAQ performance in 2016 (a 4\ub78-point difference), whereas differences between subnational locations with the highest and lowest HAQ Index values were more than two times as high for the USA and three times as high for England. State-level gaps in the HAQ Index in Mexico somewhat narrowed from 1990 to 2016 (from a 20\ub79-point to 17\ub70-point difference), whereas in Brazil, disparities slightly increased across states during this time (a 17\ub72-point to 20\ub74-point difference). Performance on the HAQ Index showed strong linkages to overall development, with high and high-middle SDI countries generally having higher scores and faster gains for non-communicable diseases. Nonetheless, countries across the development spectrum saw substantial gains in some key health service areas from 2000 to 2016, most notably vaccine-preventable diseases. Overall, national performance on the HAQ Index was positively associated with higher levels of total health spending per capita, as well as health systems inputs, but these relationships were quite heterogeneous, particularly among low-to-middle SDI countries. Interpretation GBD 2016 provides a more detailed understanding of past success and current challenges in improving personal health-care access and quality worldwide. Despite substantial gains since 2000, many low-SDI and middle- SDI countries face considerable challenges unless heightened policy action and investments focus on advancing access to and quality of health care across key health services, especially non-communicable diseases. Stagnating or minimal improvements experienced by several low-middle to high-middle SDI countries could reflect the complexities of re-orienting both primary and secondary health-care services beyond the more limited foci of the Millennium Development Goals. Alongside initiatives to strengthen public health programmes, the pursuit of universal health coverage hinges upon improving both access and quality worldwide, and thus requires adopting a more comprehensive view-and subsequent provision-of quality health care for all populations